JP3120861B2 - ニューロペプチドｙリガンドのジメシレート塩 - Google Patents

ニューロペプチドｙリガンドのジメシレート塩

Info

Publication number
JP3120861B2
JP3120861B2 JP10524469A JP52446998A JP3120861B2 JP 3120861 B2 JP3120861 B2 JP 3120861B2 JP 10524469 A JP10524469 A JP 10524469A JP 52446998 A JP52446998 A JP 52446998A JP 3120861 B2 JP3120861 B2 JP 3120861B2
Authority
JP
Japan
Prior art keywords
neuropeptide
compound
agents
salt
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP10524469A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000505110A (ja
Inventor
アレン，ダグラス・ジェイ・エム
ブロストロム，ライル・アール
コード，アリレザ・エス
ホイップル，ローリー・エイ
Original Assignee
ファイザー・インク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファイザー・インク filed Critical ファイザー・インク
Publication of JP2000505110A publication Critical patent/JP2000505110A/ja
Application granted granted Critical
Publication of JP3120861B2 publication Critical patent/JP3120861B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP10524469A 1996-11-26 1997-11-19 ニューロペプチドｙリガンドのジメシレート塩 Expired - Fee Related JP3120861B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26
US31,815 1996-11-26
US60/031,815 1996-11-26
PCT/IB1997/001465 WO1998023603A1 (en) 1996-11-26 1997-11-19 Dimesylate salts of neuropeptide y ligands

Publications (2)

Publication Number Publication Date
JP2000505110A JP2000505110A (ja) 2000-04-25
JP3120861B2 true JP3120861B2 (ja) 2000-12-25

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10524469A Expired - Fee Related JP3120861B2 (ja) 1996-11-26 1997-11-19 ニューロペプチドｙリガンドのジメシレート塩

Country Status (23)

Country Link
US (1) US5914329A (enExample)
EP (1) EP0944611B1 (enExample)
JP (1) JP3120861B2 (enExample)
AP (1) AP9701148A0 (enExample)
AR (1) AR010304A1 (enExample)
AT (1) ATE257472T1 (enExample)
AU (1) AU4792497A (enExample)
BR (1) BR9713538A (enExample)
CA (1) CA2272927C (enExample)
DE (1) DE69727155T2 (enExample)
DK (1) DK0944611T3 (enExample)
ES (1) ES2213207T3 (enExample)
GT (1) GT199700123A (enExample)
HN (1) HN1997000154A (enExample)
HR (1) HRP970640A2 (enExample)
ID (1) ID18964A (enExample)
MA (1) MA26450A1 (enExample)
PA (1) PA8441701A1 (enExample)
PE (1) PE17099A1 (enExample)
PT (1) PT944611E (enExample)
TN (1) TNSN97191A1 (enExample)
WO (1) WO1998023603A1 (enExample)
ZA (1) ZA9710587B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001232900A1 (en) * 2000-01-20 2001-07-31 Michael Amling Methods and compositions for control of bone formation via modulation of neuropeptide y activity
JP2005516001A (ja) 2001-12-05 2005-06-02 ベイラー カレッジ オブ メディスン 交感神経活動状態の調節による骨形成の制御のための方法及び組成物
NZ533848A (en) 2002-01-09 2006-11-30 Arexis Ab Detection of mutations in the flavin-containing monooxygenase (FMO3) gene
EP1701722B1 (en) * 2004-11-23 2009-10-14 Dong Wha Pharmaceutical Co., Ltd. N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy¨]pentoxy}benzamidine 2 methansulfonic acid salt
EP1877076A4 (en) * 2005-04-15 2012-02-01 Regenertech Pty Ltd USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK57097A3 (en) * 1994-11-07 1998-10-07 Pfizer Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
AP9701148A0 (en) 1998-01-31
ES2213207T3 (es) 2004-08-16
ATE257472T1 (de) 2004-01-15
AU4792497A (en) 1998-06-22
GT199700123A (es) 1999-05-19
JP2000505110A (ja) 2000-04-25
ID18964A (id) 1998-05-28
PA8441701A1 (es) 2000-05-24
CA2272927A1 (en) 1998-06-04
MA26450A1 (fr) 2004-12-20
DE69727155D1 (de) 2004-02-12
CA2272927C (en) 2003-02-04
PE17099A1 (es) 1999-02-19
DK0944611T3 (da) 2004-04-13
TNSN97191A1 (fr) 2005-03-15
US5914329A (en) 1999-06-22
DE69727155T2 (de) 2004-07-08
HRP970640A2 (en) 1998-10-31
BR9713538A (enExample) 2000-03-21
HN1997000154A (es) 1999-02-09
ZA9710587B (en) 1999-05-25
AR010304A1 (es) 2000-06-07
PT944611E (pt) 2004-04-30
EP0944611B1 (en) 2004-01-07
WO1998023603A1 (en) 1998-06-04
EP0944611A1 (en) 1999-09-29

Similar Documents

Publication Publication Date Title
JP2798095B2 (ja) 特定アミノメチルフェニルイミダゾール誘導体、新種のドーパミン受容体サブタイプの特定リガンド
US5962455A (en) Certain substituted benzylamine derivatives a new class of neuropeptide Y1 specific ligands
DE69023105T2 (de) Derivate von 1-Naphthylpiperazin, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
JP2000515151A (ja) 特定の置換ベンジルアミン誘導体；新規クラスの神経ペプチド―ｙ１特異的リガンド
JP2000515527A (ja) 特定のアミド―およびアミノ―置換ベンジルアミン誘導体；新種の神経ペプチドｙ１特異的リガンド
JP2012511020A (ja) 癌および免疫疾患の治療のためのｂｃｌ−２−選択的アポトーシス誘発剤としてのスルホンアミド誘導体
JP2003532710A (ja) モチリンアンタゴニストとして有用な新規置換ジアミン誘導体
JP4219554B2 (ja) ベンゾフラン誘導体
JP2002501050A (ja) ケモカイン受容体アンタゴニストおよびその使用方法
CN101146776A (zh) 治疗炎性疾病的pgd2受体拮抗剂
JPWO1999016768A1 (ja) ベンゾフラン誘導体
US20040209928A1 (en) Glucagon receptor antagonists/inverse agonists
WO2007017092A1 (en) Substituted 4-benzyloxy-benzoic acid amide derivatives
IE870068L (en) Decahydroquinoline derivatives
JP3120861B2 (ja) ニューロペプチドｙリガンドのジメシレート塩
EP0925295B1 (fr) Derives de n-benzenesulfonyl-l-proline en tant qu' antagonistes du recepteur b2 de la bradykinine
JP3717737B2 (ja) 神経ペプチドｙアンタゴニスト
JP2003512459A (ja) Ｐｄｅ４インヒビターとしてのフタラジノン誘導体
JP2007501244A (ja) 神経変性障害治療用オキサゾール化合物
JPS63115865A (ja) デカヒドロキノリンの新誘導体、それらの製造法及びそれらを含む薬剤
EP0929550A1 (fr) DERIVES DE $i(N)-(BENZOTHIAZOL-2-YL)PIPERIDINE-1-ETHANAMINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US6221875B1 (en) Substituted 9H-pyridino [2,3-B]indole and 9H-pyrimidino [4,5-B]indole derivatives: selective neuropeptide Y receptor ligands
JPH11130774A (ja) 神経ペプチドｙで特徴付けられ、または関連症状または障害を阻止するまたは緩和する方法
JP3041834B2 (ja) Ｎ―アミノアルキル―２―アントラキノンカルボキサミド；ドーパミンレセプターサブタイプに特異的な新しい配位子
JPH05506440A (ja) アルコキシ置換ジヒドロベンゾピラン―２―カルボン酸およびその誘導体

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees